经导管主动脉瓣置换术后并发症的防治研究进展  

Advances in prevention and treatment of complications after transcatheter aortic valve replacement

作　　者：周道 戚鑫瑞 朱齐丰[1] 戴晗怡 刘先宝[1] 王建安[1] ZHOU Dao;QI Xin-rui;ZHU Qi-feng;DAI Han-yi;LIU Xian-bao;WANG Jian-an(Department of Cardiology,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310000,China)

机构地区：[1]浙江大学医学院附属第二医院心血管内科,浙江杭州310000

出　　处：《内科急危重症杂志》2021年第6期448-452,共5页Journal of Critical Care In Internal Medicine

基　　金：浙江省科技厅重点研发计划(2021C03097,2018C03084)。

摘　　要：根据国际最新心脏瓣膜病管理指南,经导管主动脉瓣置换术(TAVR)是重度主动脉瓣狭窄的主要治疗方式。随着TAVR手术应用于更多人群、瓣膜研究学术联盟共识-3(VARC-3)对临床事件的重新定义,TAVR术后的并发症需要得到更多的关注,因此,本文就血管并发症、冠脉阻塞、新发传导阻滞、脑卒中和脑保护装置、瓣叶血栓和瓣叶衰败等并发症的研究进展作一综述,以增加临床工作者对TAVR术后并发症的认识。Transcatheter aortic valve replacement(TAVR)is an important treatment for severe aortic stenosis according to the updated guideline of valvular heart disease.As Valve Academic Research Consortium-3 has updated the definition of the clinical events and there would be more patients receiving TAVR in the future,clinicians should pay more attention to complications after TAVR.This study reviews the advances and frontiers in TAVR's complications such as vascular complications,coronary obstruction,new-onset conduction disturbance,stroke and cerebral protection device,valve thrombosis,structure valve deterioration and bioprosthetic valve failure etc,in order to increase the understanding of complications after TAVR.

关 键 词：导管主动脉瓣置换术 并发症 临床事件 瓣膜研究学术联盟共识-3 

分 类 号：R542.5[医药卫生—心血管疾病] R654.2[医药卫生—内科学]